Life Scientia Limited;
Takeda Pharmaceutical Company Limited; and.
PDA J Pharm Sci Technol. 2021 Nov-Dec;75(6):490-505. doi: 10.5731/pdajpst.2018.009308. Epub 2021 May 14.
To develop a guide of best practices for establishing appropriate controls on nonsterile manufacturing environments for pharmaceutical manufacturers, the Kansai Study Group of the Parenteral Drug Association Japan Chapter explored relevant issues in-depth and published the results of their study, "The Study in Risk-Based Manufacturing Environmental Control for Non-Sterile Drug Products" in the n. This review summarizes the background of that study and the structure of the published article and, to help readers make the most of the contents, provides a table displaying the category, subject, problem statement, and points to consider of each topic discussed in the article, as well as examples of central topics (Appendices 1-3).
为了为制药商制定非无菌生产环境的适当控制措施制定最佳实践指南,日本药剂师协会关西分会的研究小组深入探讨了相关问题,并在 n 上发表了他们的研究结果,“基于风险的非无菌药品生产环境控制研究”。本文综述了该研究的背景和已发表文章的结构,并为帮助读者充分利用本文内容,提供了一个表格,展示了文章中讨论的每个主题的类别、主题、问题陈述和需要考虑的要点,以及一些核心主题的示例(附录 1-3)。